These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35558375)

  • 1. Splint Duration and Not the Mode of Anesthesia Is the Main Factor Influencing Avascular Necrosis After Closed Reduction for Developmental Dysplasia of the Hip in Kosovo.
    Sllamniku S; Beqo BP; Krasniqi I; Tërshana A; Murtezani A; Quehenberger F; Haxhija EQ
    Front Pediatr; 2022; 10():850605. PubMed ID: 35558375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Perfusion MRI After Closed Reduction of Developmental Dysplasia of the Hip Reduce the Incidence of Avascular Necrosis?
    Gornitzky AL; Georgiadis AG; Seeley MA; Horn BD; Sankar WN
    Clin Orthop Relat Res; 2016 May; 474(5):1153-65. PubMed ID: 26092677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between avascular necrosis and the presence of the ossific nucleus when treating developmental dysplasia of the hip.
    Sllamniku S; Bytyqi C; Murtezani A; Haxhija EQ
    J Child Orthop; 2013 Dec; 7(6):501-5. PubMed ID: 24432113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for avascular necrosis after closed reduction for developmental dysplasia of the hip.
    Schur MD; Lee C; Arkader A; Catalano A; Choi PD
    J Child Orthop; 2016 Jun; 10(3):185-92. PubMed ID: 27177477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hip arthrogram parameters predict radiographic outcomes of patients with developmental dysplasia of the hip treated by closed reduction.
    Tan Y; Zhao W; Wei M; He Y; Deng H; Su D; Zhu W; Wu Y; Shen H; Li Y
    Front Pediatr; 2023; 11():1292928. PubMed ID: 38283401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avascular necrosis predictive factors after closed reduction in patients with developmental dysplasia of the hip.
    Kheiri S; Tahririan MA; Shahnaser S; Ardakani MP
    J Res Med Sci; 2023; 28():81. PubMed ID: 38292338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avascular necrosis of the femoral head: Assessment following developmental dysplasia of the hip management.
    Al Faleh AF; Jawadi AH; Sayegh SA; Al Rashedan BS; Al Shehri M; Al Shahrani A
    Int J Health Sci (Qassim); 2020; 14(1):20-23. PubMed ID: 31983917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prereduction traction for the prevention of avascular necrosis before closed reduction for developmental dysplasia of the hip: a meta-analysis.
    Park KB; Vaidya VN; Shin H; Kwak YH
    Ther Clin Risk Manag; 2018; 14():1253-1260. PubMed ID: 30087565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-closed reduction perfusion magnetic resonance imaging as a predictor of avascular necrosis in developmental hip dysplasia: a preliminary report.
    Tiderius C; Jaramillo D; Connolly S; Griffey M; Rodriguez DP; Kasser JR; Millis MB; Zurakowski D; Kim YJ
    J Pediatr Orthop; 2009; 29(1):14-20. PubMed ID: 19098638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tönnis and the Novel IHDI Radiographic Classification Systems for the Developmental Dysplasia of The Hip (DDH): Evaluation of 406 hips with DDH.
    Yilar S; Topal M
    Acta Orthop Belg; 2023 Mar; 89(1):21-27. PubMed ID: 37294981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Closed reduction and plaster immobilization: an alternative solution for patients with developmental dysplasia of the hip who failed Pavlik harness treatment.
    Zhou P; Zhang J; Dan T; Xu T; Kang X; Hang Y; Zhou Y
    ANZ J Surg; 2023 Mar; 93(3):663-668. PubMed ID: 36732905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of treatment outcomes of stable and unstable developmental dysplasia of the hip with the Tübingen splint.
    Chaibi E; Saugy CA; Samara E; Zambelli PY; Merckaert SR
    Front Pediatr; 2022; 10():976367. PubMed ID: 36090577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should closed reduction of the dislocated hip be attempted after failed Pavlik harness treatment in developmental dysplasia of the hip?
    Arneill M; Cosgrove A; Robinson E
    Bone Jt Open; 2021 Aug; 2(8):584-588. PubMed ID: 34351213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between the Pavlik harness and the Tübingen hip flexion splint for the early treatment of developmental dysplasia of the hip.
    Ran L; Chen H; Pan Y; Lin Q; Canavese F; Chen S
    J Pediatr Orthop B; 2020 Sep; 29(5):424-430. PubMed ID: 31503108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for avascular necrosis after closed hip reduction in developmental dysplasia of the hip.
    Sibiński M; Synder M; Domzalski M; Grzegorzewski A
    Ortop Traumatol Rehabil; 2004 Feb; 6(1):60-6. PubMed ID: 17676009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified Smith-Petersen approach with rectus-sparing reduces severe avascular necrosis for developmental dysplasia of the hip at walking age: minimum 5-year follow-up.
    Miao M; Jin S; Cai H; Cai H; Bian J; Wang Z
    J Orthop Surg Res; 2022 Dec; 17(1):539. PubMed ID: 36514173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of abduction on avascular necrosis of the femoral epiphysis in patients with late-detected developmental dysplasia of the hip treated by closed reduction: a MRI study of 59 hips.
    Liu YH; Xu HW; Li YQ; Hong K; Li JC; Pereira B; Xun FX; Canavese F
    J Child Orthop; 2019 Oct; 13(5):438-444. PubMed ID: 31695810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with unsatisfactory hip function in children with late-diagnosed developmental dislocation of the hip treated by open reduction.
    Li Y; Hu W; Xun F; Lin X; Li J; Yuan Z; Liu Y; Canavese F; Xu H
    Orthop Traumatol Surg Res; 2020 Nov; 106(7):1373-1381. PubMed ID: 32571742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splinting for the non-operative management of developmental dysplasia of the hip (DDH) in children under six months of age.
    Dwan K; Kirkham J; Paton RW; Morley E; Newton AW; Perry DC
    Cochrane Database Syst Rev; 2022 Oct; 10(10):CD012717. PubMed ID: 36214650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse Outcomes in Infantile Bilateral Developmental Dysplasia of the Hip.
    Morbi AH; Carsi B; Gorianinov V; Clarke NM
    J Pediatr Orthop; 2015; 35(5):490-5. PubMed ID: 25171675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.